E. ARARAT Et Al. , "Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma," BRITISH JOURNAL OF HAEMATOLOGY , vol.151, no.5, pp.530-531, 2010
ARARAT, E. Et Al. 2010. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , vol.151, no.5 , 530-531.
ARARAT, E., SAHIN, I., Ozdemir, E., & ALTUNDAG, K., (2010). Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , vol.151, no.5, 530-531.
ARARAT, Erhan Et Al. "Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma," BRITISH JOURNAL OF HAEMATOLOGY , vol.151, no.5, 530-531, 2010
ARARAT, Erhan Et Al. "Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma." BRITISH JOURNAL OF HAEMATOLOGY , vol.151, no.5, pp.530-531, 2010
ARARAT, E. Et Al. (2010) . "Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma." BRITISH JOURNAL OF HAEMATOLOGY , vol.151, no.5, pp.530-531.
@article{article, author={Erhan ARARAT Et Al. }, title={Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma}, journal={BRITISH JOURNAL OF HAEMATOLOGY}, year=2010, pages={530-531} }